1. Home
  2. SLS vs AISP Comparison

SLS vs AISP Comparison

Compare SLS & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • AISP
  • Stock Information
  • Founded
  • SLS 2012
  • AISP 2006
  • Country
  • SLS United States
  • AISP United States
  • Employees
  • SLS N/A
  • AISP N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • AISP Blank Checks
  • Sector
  • SLS Health Care
  • AISP Finance
  • Exchange
  • SLS Nasdaq
  • AISP Nasdaq
  • Market Cap
  • SLS 165.6M
  • AISP 166.9M
  • IPO Year
  • SLS N/A
  • AISP N/A
  • Fundamental
  • Price
  • SLS $1.66
  • AISP $4.96
  • Analyst Decision
  • SLS Strong Buy
  • AISP Strong Buy
  • Analyst Count
  • SLS 1
  • AISP 1
  • Target Price
  • SLS $7.00
  • AISP $6.00
  • AVG Volume (30 Days)
  • SLS 2.8M
  • AISP 1.2M
  • Earning Date
  • SLS 08-12-2025
  • AISP 08-13-2025
  • Dividend Yield
  • SLS N/A
  • AISP N/A
  • EPS Growth
  • SLS N/A
  • AISP N/A
  • EPS
  • SLS N/A
  • AISP N/A
  • Revenue
  • SLS N/A
  • AISP $17,978,226.00
  • Revenue This Year
  • SLS N/A
  • AISP $34.52
  • Revenue Next Year
  • SLS N/A
  • AISP $59.54
  • P/E Ratio
  • SLS N/A
  • AISP N/A
  • Revenue Growth
  • SLS N/A
  • AISP N/A
  • 52 Week Low
  • SLS $0.77
  • AISP $1.90
  • 52 Week High
  • SLS $2.27
  • AISP $7.66
  • Technical
  • Relative Strength Index (RSI)
  • SLS 41.18
  • AISP 41.19
  • Support Level
  • SLS $1.75
  • AISP $5.05
  • Resistance Level
  • SLS $1.96
  • AISP $5.34
  • Average True Range (ATR)
  • SLS 0.12
  • AISP 0.39
  • MACD
  • SLS -0.04
  • AISP -0.09
  • Stochastic Oscillator
  • SLS 18.56
  • AISP 10.67

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

Share on Social Networks: